 CAMBRIDGE, Mass., April 21, 2022 GLOBE NEWSWIRE -- Spero Therapeutics, Inc. Nasdaq: SPRO today announced two oral presentations and four poster presentations at the 32nd European Congress of Clinical Microbiology and Infectious Diseases ECCMID being held April 23-26, 2022, in Lisbon, Portugal. 